Combination of antibodies inhibits accelerated rejection mediated by memory T cells in xenoantigen-primed mice

Xenotransplantation

Volumn 17, Issue 6, 2010, Pages 460-468

  Wang, Feiyu ^a   Xia, Junjie ^a   Chen, Jibing ^a   Peng, Yuanzheng ^a   Cheng, Panpan ^a   Ekberg, Henrik ^b   Wang, Xiaomin ^a   Qi, Zhongquan ^a  

^a XIAMEN UNIVERSITY   (China)

^b LUND UNIVERSITY   (Sweden)

Author keywords

combined antibodies; donor reactive memory T cell; islet xenotransplantation

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN; GAMMA INTERFERON; HETEROANTIGEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR BETA MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; OX40 LIGAND; OX40 LIGAND MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; LEWIS RAT; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; SPLEEN LYMPHOCYTE; STREPTOZOCIN DIABETES; SURVIVAL TIME; XENOGRAFT; XENOTRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES; ANTIGENS, HETEROPHILE; GRAFT REJECTION; IMMUNOLOGIC MEMORY; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, INBRED LEW; T-LYMPHOCYTES;

EID: 78650641856     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2010.00618.x     Document Type: Article

References (36)

1. Buhler L, Friedman T, Iacomini J, Cooper DK,. Xenotransplantation-state of the art-update 1999. Front Biosci. 1999; 4: D416-D432.
2. Auchincloss H Jr, Sachs DH,. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433-470.
3. Cascalho M, Platt JL,. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437-446.
4. June CH, Bluestone JA, Nadler LM, Thompson CB,. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321-331.
5. + T cell apoptosis but not immune deviation. Transplantation 2000; 69: 1176-1185.
6. Bucher P, Gang M, Morel P, et al. Transplantation of discordant xenogeneic islets using repeated therapy with anti-CD154. Transplantation 2005; 79: 1545-1552.
7. Mai G, Bucher P, Morel P, et al. Anti-CD154 mAb treatment but not recipient CD154 deficiency leads to long-term survival of xenogeneic islet grafts. Am J Transplant 2005; 5: 1021-1031.
8. Mai G, Del Rio ML, Tian J, Ramirez P, Buhler L, Rodriguez-Barbosa JI,. Blockade of the PD-1/PD-1L pathway reverses the protective effect of anti-CD40L therapy in a rat to mouse concordant islet xenotransplantation model. Xenotransplantation 2007; 14: 243-248.
9. Triponez F, Oberholzer J, Morel P, et al. Xenogeneic islet re-transplantation in mice triggers an accelerated, species-specific rejection. Immunology 2000; 101: 548-554.
10. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol 2002; 169: 4667-4673.
11. Valujskikh A, Pantenburg B, Heeger PS,. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002; 2: 501-509.
12. + T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004; 172: 5456-5466.
13. Paterson DJ, Jefferies WA, Green JR, et al. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987; 24: 1281-1290.
14. Takasawa N, Ishii N, Higashimura N, et al. Expression of gp34 (OX40 ligand) and OX40 on human T cell clones. Jpn J Cancer Res 2001; 92: 377-382.
15. Stuber E, Strober W,. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 1996; 183: 979-989.
16. Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G,. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997; 159: 3838-3848.
17. Imura A, Hori T, Imada K, et al. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 1996; 183: 2185-2195.
18. Sugamura K, Ishii N, Weinberg AD,. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 2004; 4: 420-431.
19. Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC,. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol 2006; 176: 1394-1401.
20. Minamimura K, Sato K, Yagita H, Tanaka T, Arii S, Maki T,. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice. Am J Transplant 2008; 8: 761-772.
21. Cho BK, Wang C, Sugawa S, Eisen HN, Chen J,. Functional differences between memory and naive CD8 T cells. Proc Natl Acad Sci U S A 1999; 96: 2976-2981.
22. Madakamutil LT, Christen U, Lena CJ, et al. CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science 2004; 304: 590-593.
23. Xia J, Chen J, Shao W, et al. Suppressing memory T cell activation induces islet allograft tolerance in alloantigen-primed mice. Transpl Int 2010; 23: 1154-1163.
24. Muller YD, Golshayan D, Ehirchiou D, Wekerle T, Seebach JD, Buhler LH,. T regulatory cells in xenotransplantation. Xenotransplantation 2009; 16: 121-128.
25. Muller YD, Mai G, Morel P, et al. Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in rat-to-mouse islet transplantation. PLoS ONE 2010; 5: e10352.
26. Valujskikh A, Baldwin WM III, Fairchild RL,. Recent progress and new perspectives in studying T cell responses to allografts. Am J Transplant 2010; 10: 1117-1125.
27. Adams AB, Pearson TC, Larsen CP,. Heterologous immunity: an overlooked barrier to tolerance. Immunol Rev 2003; 196: 147-160.
28. Bingaman AW, Farber DL,. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 2004; 4: 846-852.
29. Shevach EM,. Regulatory T cells in autoimmmunity*. Annu Rev Immunol 2000; 18: 423-449.
30. Sanchez-Fueyo A, Weber M, Domenig C, Strom TB, Zheng XX,. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002; 168: 2274-2281.
31. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+ CD25+ Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14: 88-92.
32. Porter CM, Bloom ET,. Human CD4+ CD25 + regulatory T cells suppress anti-porcine xenogeneic responses. Am J Transplant 2005; 5: 2052-2057.
33. Wu J, Yi S, Ouyang L, et al. In vitro expanded human CD4 + CD25 + regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008; 85: 1841-1848.
34. Arefanian H, Tredget EB, Rajotte RV, Gill RG, Korbutt GS, Rayat GR,. Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice. Diabetes. 2010: 59: 958-966.
35. Elwood ET, Larsen CP, Cho HR, et al. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 1998; 65: 1422-1428.
36. Nabeyama K, Yasunami Y, Toyofuku A, et al. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse. Transplantation 2004; 78: 1590-1596.